หน้าแรก
ค้นหา
Dr. Melisko on Duration of Aromatase Inhibitor Use in Breast Cancer
No description available
แสดงข้อมูลเพิ่มเติม 1
Dr. Melisko on Duration of Aromatase Inhibitor Use in Breast Cancer
Dr. Melisko on the MA.17R Study for ER+ Breast Cancer
Dr. Melisko Reflects on Findings From the MINDACT Trial in Breast Cancer
NEJM Trial Summary: Duration of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer
Dr. Tripathy on 10 Versus 5 Years of Aromatase Inhibitors
Dr. Cristofanilli on Aromatase Inhibitor Adverse Events in Breast Cancer
CDK4/6 Inhibitors for Breast Cancer: A Guide for Patients
UCSF Bay Area Breast Cancer Forum: Breast Cancer at ASCO 2021: Hear from the experts!
Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer
UCSF Bay Area Breast Cancer Forum: Updates from the San Antonio Breast Cancer Symposium 2021
Aromatase Inhibitors and Breast Cancer Therapy
Naturopathic Integrative Oncology and Aromatase Inhibitors in Breast Cancer Treatment
Breast Cancer Oncology Course, Spring 2010, UCSF Video #4/11
Options for Treatment-Naive Metastatic ER+ Breast Cancer
Novel Strategies for Treatment of Early Breast Cancer, Part I
Enhancing the Effectiveness of Hormonal Therapy in Breast Cancer using Natural Medicines pt 1
UCSF Bay Area Breast Cancer Forum: "Updates from ASCO 2025”
UCSF Bay Area Breast Cancer Forum: Updates from ASCO 2022
Breast Cancer Oncology Course, Spring 2010, Video #3/11
UCSF Bay Area Breast Cancer Forum: "Updates from San Antonio Breast Cancer Symposium 2023"
